Page last updated: 2024-08-26

tretazicar and nad

tretazicar has been researched along with nad in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's4 (50.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Friedlos, F; Knox, RJ1
Abrahamson, JA; Biggs, PJ; Friedlos, F; Knox, RJ1
Baer, J; Bagshawe, KD; Sunters, A1
Friedlos, F; Jarman, M; Knox, RJ; Roberts, JJ1
Anlezark, GM; Davies, LC; Friedlos, F; Goddard, P; Jarman, M; Knox, RJ; Melton, RG; Sherwood, RF1
Helsby, NA; Tang, MH; Tingle, MD; Wilson, WR1
Boddy, AV; Jamieson, D; Knox, RJ; Tung, AT1
Anderson, JLR; Christofferson, AJ; Day, MA; Evans, A; Hyde, EI; Searle, PF; Vass, SO; White, SA1

Other Studies

8 other study(ies) available for tretazicar and nad

ArticleYear
Metabolism of NAD(P)H by blood components. Relevance to bioreductively activated prodrugs in a targeted enzyme therapy system.
    Biochemical pharmacology, 1992, Aug-18, Volume: 44, Issue:4

    Topics: Animals; Antineoplastic Agents; Aziridines; Biotransformation; Blood; Blood Coagulation; Cattle; Dihydrolipoamide Dehydrogenase; Horses; Humans; Hydrolysis; Lactates; NAD; NADP; Niacinamide; Oxidation-Reduction; Prodrugs; Tumor Cells, Cultured

1992
Potentiation of CB 1954 cytotoxicity by reduced pyridine nucleotides in human tumour cells by stimulation of DT diaphorase activity.
    Biochemical pharmacology, 1992, Nov-03, Volume: 44, Issue:9

    Topics: Antineoplastic Agents; Aziridines; DNA, Neoplasm; Drug Synergism; Humans; Intracellular Fluid; Kinetics; NAD; NAD(P)H Dehydrogenase (Quinone); Niacinamide; Pyridinium Compounds; Ribonucleosides; Stimulation, Chemical; Tumor Cells, Cultured

1992
Cytotoxicity and activation of CB1954 in a human tumour cell line.
    Biochemical pharmacology, 1991, May-01, Volume: 41, Issue:9

    Topics: Animals; Antineoplastic Agents; Aziridines; Biotransformation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; NAD; Nitroreductases; Prodrugs; Tumor Cells, Cultured

1991
A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells.
    Biochemical pharmacology, 1988, Dec-15, Volume: 37, Issue:24

    Topics: Animals; Antineoplastic Agents; Aziridines; Azirines; Carcinoma 256, Walker; Cell Survival; Cricetinae; Cross-Linking Reagents; DNA Damage; NAD; Nitroreductases; Oxidoreductases; Rats; Tumor Cells, Cultured

1988
Virtual cofactors for an Escherichia coli nitroreductase enzyme: relevance to reductively activated prodrugs in antibody directed enzyme prodrug therapy (ADEPT).
    Biochemical pharmacology, 1995, May-26, Volume: 49, Issue:11

    Topics: Animals; Antibodies; Aziridines; Escherichia coli; Mice; NAD; Nitroreductases; Oxidation-Reduction; Prodrugs; Pyridinium Compounds; Ribonucleosides; Vitamin K

1995
Aerobic 2- and 4-nitroreduction of CB 1954 by human liver.
    Toxicology, 2005, Dec-15, Volume: 216, Issue:2-3

    Topics: Antineoplastic Agents; Aziridines; Carbon Monoxide; Chromatography, High Pressure Liquid; Clinical Trials, Phase I as Topic; Cytosol; Cytotoxins; Dicumarol; Escherichia coli; Humans; Hydroxylamines; Hypoxia; Liver; Mass Spectrometry; Microsomes, Liver; NAD; NADP; Nitroreductases; Prodrugs

2005
Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor.
    British journal of cancer, 2006, Nov-06, Volume: 95, Issue:9

    Topics: Alkylating Agents; Animals; Aziridines; Catalysis; Cell Line; Comet Assay; Electron Transport; Humans; Mitomycin; NAD; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Quercetin; Quinone Reductases; Recombinant Proteins; Transfection

2006
Structure and Dynamics of Three
    International journal of molecular sciences, 2023, Mar-22, Volume: 24, Issue:6

    Topics: Escherichia coli; Escherichia coli Proteins; Humans; NAD; Neoplasms; Nitroreductases; Oxidoreductases; Prodrugs

2023